Showing 12 of 12 recruiting trials for “Intraductal papillary mucinous carcinoma of pancreas”
RecruitingNCT07216521 ↗
Intent of Surgery for IPMN
RecruitingNCT07117045 ↗
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
RecruitingNCT06574373 ↗
Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression
👨⚕️ Carmine Carbone, PhD, Fondazione Policlinico Universitario Agostino Gemelli IRCCS📍 2 sites📅 Started May 2025View details ↗
RecruitingNCT06694792 ↗
Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers Detection (INCITE) Consortium
Enrolling by InvitationNCT06276764 ↗
The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
RecruitingNCT06638866 ↗
AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening Cohort
Enrolling by InvitationNCT06283576 ↗
Pancreatic Cancer Initial Detection Via Liquid Biopsy
RecruitingNCT05433935 ↗
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
RecruitingNCT05117723 ↗
Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
RecruitingNCT06706700 ↗
Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas
RecruitingNCT04275557 ↗
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
RecruitingNCT03492151 ↗
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →